Alpine Immune Sciences Announces Appointment of Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer and Grant under Nasdaq Listing Rule 5635(c)
SEATTLE--(BUSINESS WIRE)--Oct 4, 2023--
Stay updated with breaking news from Wolfgang Dummer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE--(BUSINESS WIRE)--Oct 4, 2023--
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced it dosed the first patient in its Phase 1b study of R289, an IRAK1/4 dual inhibitor,...
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the publication of data in The Lancet Haematology, which summarizes the Phase 1...
Rigel Pharmaceuticals, Inc. (NASDAQ:NASDAQ:RIGL) Q2 2022 Earnings Conference Call August 02, 2022, 04:30 PM ET Company Participants Dolly Vance - Executive Vice President, Corporate Affairs...
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today provided a business update including preliminary 2021 full-year total revenue, the status of...